236 related articles for article (PubMed ID: 16365024)
1. Nipple fluid basic fibroblast growth factor in patients with breast cancer.
Sartippour MR; Zhang L; Lu M; Wang HJ; Brooks MN
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2995-8. PubMed ID: 16365024
[TBL] [Abstract][Full Text] [Related]
2. Nipple aspirate fluid collection, related factors and relationship between carcinoembryonic antigen in nipple aspirate fluid and breast diseases in women in Harbin, PRC.
Zhao YS; Pang D; Wang F; Xue YW; Gao DN; Li H; Li K; Wang BY; Wang D; Li HY
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):732-8. PubMed ID: 19273481
[TBL] [Abstract][Full Text] [Related]
3. Breast-cancer diagnosis with nipple fluid bFGF.
Liu Y; Wang JL; Chang H; Barsky SH; Nguyen M
Lancet; 2000 Aug; 356(9229):567. PubMed ID: 10950239
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers associated with breast cancer are associated with obesity.
Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
[TBL] [Abstract][Full Text] [Related]
5. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid.
Li J; Zhao J; Yu X; Lange J; Kuerer H; Krishnamurthy S; Schilling E; Khan SA; Sukumar S; Chan DW
Clin Cancer Res; 2005 Dec; 11(23):8312-20. PubMed ID: 16322290
[TBL] [Abstract][Full Text] [Related]
6. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection.
Kumar SR; Sauter ER; Quinn TP; Deutscher SL
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6868-71. PubMed ID: 16203776
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk.
Sauter ER; Daly M; Linahan K; Ehya H; Engstrom PF; Bonney G; Ross EA; Yu H; Diamandis E
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):967-70. PubMed ID: 8959318
[TBL] [Abstract][Full Text] [Related]
8. Nipple aspirate fluid color is associated with breast cancer.
Sauter ER; Winn JN; Dale PS; Wagner-Mann C
Cancer Detect Prev; 2006; 30(4):322-8. PubMed ID: 16963197
[TBL] [Abstract][Full Text] [Related]
9. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.
Buehring GC; Letscher A; McGirr KM; Khandhar S; Che LH; Nguyen CT; Hackett AJ
Breast Cancer Res Treat; 2006 Jul; 98(1):63-70. PubMed ID: 16685591
[TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?
Granato AM; Nanni O; Falcini F; Folli S; Mosconi G; De Paola F; Medri L; Amadori D; Volpi A
Breast Cancer Res; 2004; 6(1):R38-45. PubMed ID: 14680499
[TBL] [Abstract][Full Text] [Related]
11. Serum bFGF (basic fibroblast growth factor) and CA 15.3 in the monitoring of breast cancer patients.
Pichon MF; Moulin G; Pallud C; Pecking A; Floiras JL
Anticancer Res; 2000; 20(2B):1189-94. PubMed ID: 10810420
[TBL] [Abstract][Full Text] [Related]
12. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
Ławicki S; Szmitkowski M; Wojtukiewicz M
Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
[TBL] [Abstract][Full Text] [Related]
13. High basic fibroblast growth factor levels in nipple aspirate fluid are correlated with breast cancer.
Hsiung R; Zhu W; Klein G; Qin W; Rosenberg A; Park P; Rosato E; Sauter E
Cancer J; 2002; 8(4):303-10. PubMed ID: 12184408
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.
Pawlik TM; Hawke DH; Liu Y; Krishnamurthy S; Fritsche H; Hunt KK; Kuerer HM
BMC Cancer; 2006 Mar; 6():68. PubMed ID: 16542425
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen in breast nipple aspirate fluid.
Foretova L; Garber JE; Sadowsky NL; Verselis SJ; Joseph DM; Andrade AF; Gudrais PG; Fairclough D; Li FP
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):195-8. PubMed ID: 9521431
[TBL] [Abstract][Full Text] [Related]
16. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
[TBL] [Abstract][Full Text] [Related]
17. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts.
Zhao Y; Verselis SJ; Klar N; Sadowsky NL; Kaelin CM; Smith B; Foretova L; Li FP
J Clin Oncol; 2001 Mar; 19(5):1462-7. PubMed ID: 11230492
[TBL] [Abstract][Full Text] [Related]
18. Patient variables that predict atypical cytology by nipple duct lavage.
Bushnaq ZI; Ashfaq R; Leitch AM; Euhus D
Cancer; 2007 Apr; 109(7):1247-54. PubMed ID: 17326050
[TBL] [Abstract][Full Text] [Related]
19. Elevation of serum riboflavin carrier protein in breast cancer.
Rao PN; Levine E; Myers MO; Prakash V; Watson J; Stolier A; Kopicko JJ; Kissinger P; Raj SG; Raj MH
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):985-90. PubMed ID: 10566553
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of nipple fluid for breast cancer screening.
Suijkerbuijk KP; van der Wall E; Vooijs M; van Diest PJ
Pathobiology; 2008; 75(2):149-52. PubMed ID: 18544970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
